0 — Class I drug recall D-1592-2014
Terminated recall by Baxter Healthcare Corp., reported 2014-09-24, distributed nationwide. Presence of Particulate Matter: particulate matter identified as fibers and/or plastics.
| Recall number | D-1592-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Baxter Healthcare Corp., Deerfield, IL, United States |
| Recall initiated | 2014-07-11 |
| Classified | 2014-09-18 |
| Reported by FDA | 2014-09-24 |
| Terminated | 2016-09-21 |
| Distributed | Nationwide (US) |
| Countries outside the US | HK, SG |
| Quantity | 390,560 bags |
| Reason classes | specification failure |
| NDC | 00338-0553, 00338-0553-11, 00338-0553-18 |
| Lot numbers | 10/14, P308650 |
Product
0.9% Sodium Chloride Injection USP MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0553-18, Product Code 2B0043.
Reason for recall
Presence of Particulate Matter: particulate matter identified as fibers and/or plastics.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1592-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.